REMPLIR - MODELING EPINEURIAL STRUCTURE
LIVE

Serial Number

79414297

Owner

Orthocell Limited

Attorney

Matthew J. Stark

Filing Date

Dec 16, 2024

Add to watchlist:

No watchlists yet
View on USPTO

REMPLIR - MODELING EPINEURIAL STRUCTURE Trademark

Serial Number: 79414297 • Registration: 8217291

REMPLIR - MODELING EPINEURIAL STRUCTURE is a trademark filed by Orthocell Limited on December 16, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Orthocell Limited (16 trademarks)

Building 191,

Entity Type: 99

Trademark Details

Filing Date

December 16, 2024

Registration Date

April 21, 2026

Published for Opposition

March 3, 2026

Goods & Services

Orthopaedic apparatus, namely, apparatus made from artificial biomaterials for use in the regeneration of bone and soft tissue, including nerve tissue; orthopaedic articles, namely, apparatus made from artificial biomaterials for use in the regeneration of bone and soft tissue, including nerve tissue; medical implants made from artificial materials; surgical implants comprised of artificial materials; surgical implants comprised of artificial materials for use in guided tissue regeneration; orthopaedic implants, namely, implants made from artificial biomaterials for use in the regeneration of bone and soft tissue, including nerve tissue; artificial orthopaedic implants, namely, implants made from artificial biomaterials for use in the regeneration of bone and soft tissue, including nerve tissue; implants being prostheses of artificial biomaterials, namely, bone prostheses and soft tissue prostheses for replacing bone and soft tissue for use in the body; implants being prostheses of artificial biomaterials, namely, dental prostheses for dental surgery; implants being prostheses of artificial biomaterials, namely, bone prostheses for bone surgery; implants being prostheses of artificial biomaterials, namely, dental and bone prostheses for use in facial surgery; implants being prostheses of artificial biomaterials, namely, bone prostheses for use in bone grafting; otological prostheses being prostheses consisting of artificial biomaterials; dental implants; artificial surgical implants comprising artificial biomaterials; therapeutic articles for implantation, namely, surgical implants, made of artificial materials

Collagen for medical purposes; surgical implants grown from stem cells being living tissue; therapeutic drugs and agents for use in tissue repair and regeneration; pharmaceutical and medical preparations for use in regeneration of damaged bone and soft tissue, including nerve tissue; surgical and medical dressings; biological preparations for medical purposes, namely, for use in tissue regeneration for tissue repair; biological preparations for medical use, namely, for use in tissue regeneration for tissue repair; dental implant materials being implantable scaffolds comprising biological materials including living cells and collagen; collagen bioinks in the nature of biological tissues intended for subsequent implantation for clinical purposes; biological implants comprised of human or animal connective tissues intended for subsequent implantation; biological implants, namely, living cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair; surgical implants comprised of living tissues; surgical mesh comprised primarily of living tissue; biotechnological preparations for medical purposes, namely, living cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair; biodegradable implants for use in guided tissue regeneration, namely, living cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair; collagen bioinks in the nature of biological tissue cells intended for subsequent implantation for clinical purposes; engineered human biological tissues being living cells and implantable scaffolds comprising biological materials for use in regenerative medicine; engineered animal biological tissues being living cells and implantable scaffolds comprising biological materials for use in regenerative medicine; biomaterials in the nature of biological tissue cells being living cells for medical purposes; biological tissue being living cells for implantation for use in tissue regeneration for tissue repair; engineered biological tissues being living cells for medical purposes

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 21, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 25, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 8, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 8, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 21, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 29, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 29, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 29, 2026 TROA
REFUSAL PROCESSED BY IB
Aug 15, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 30, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jul 30, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 10, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jun 9, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 2, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 10, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 9, 2025 REPR